Market Expansion Opportunities Navamedic's presence across all Nordic countries, the Baltics, and Benelux, along with sales in the UK and Greece, suggests strong geographic expansion potential. Partnering with regional distributors or healthcare providers in these markets could boost sales of existing products and facilitate the launch of new offerings.

Product Innovation & Diversification Recent launches like ForlaxGO and Modifast, along with partnerships for innovative treatments like Sitavig and Eroxon, point to an openness to expanding into new pharmaceutical segments and over-the-counter health products, creating opportunities for sales teams to introduce complementary products and diagnostics.

Strategic Partnership Potential The collaboration with Alex Therapeutics to develop digital health tools demonstrates Navamedic’s interest in digital health solutions. This opens doors for sales opportunities in digital therapeutics, remote monitoring, and personalized medicine offerings tailored to healthcare providers and payers.

Targeted Hospital & Pharmacy Channels With a focus on high-quality pharmaceuticals supplied to hospitals and pharmacies, there is potential for sales growth by strengthening relationships within hospital networks, specialty clinics, and pharmacy chains, especially in regions where new product launches are underway.

Growth through Acquisition The recent acquisition of Sensidose indicates a growth strategy through adding innovative companies. Identifying similar mid-sized firms with proprietary drugs or medical devices can present new sales channels and product lines aligned with Navamedic's portfolio.